Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.11% slid 2.07% to $167.14 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.34% rising 0.08% to 33,336.67 and the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.01% falling 0.07% to 4,207.27. Johnson & Johnson closed $19.55 below its 52-week high ($186.69), which the company reached on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -2.39% fell 2.52% to $325.64, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.02% fell 0.29% to $88.93, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.51% fell 3.32% to $48.29. Trading volume (9.3 M) eclipsed its 50-day average volume of 6.7 M.